Welichem Biotech is Pharmaceuticals in Canada that focus on Symbiochem technology platform business. Founded in 1995. They cover business area such as developer, therapeutic drug, autoimmune disease, development, small molecule therapeutic, its Symbiochem technology platform, a pipeline, protect compound, autoimmune inflammatory disease, cancer.
1995
( 29 years old in 2024 )
Symbiochem Technology Platform
-
4475 Wayburne Drive
Suite 316
Burnaby, British Columbia V5G 3L1
Canada
Private
developertherapeutic drugautoimmune diseasedevelopmentsmall molecule therapeuticits Symbiochem technology platforma pipelineprotect compoundautoimmune inflammatory diseasecancer
* We use standard office opening hours in near Welichem Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Welichem Biotech is Pharmaceuticals business from Canada that founded in 1995 (29 years old in 2024), Welichem Biotech business is focusing on Symbiochem Technology Platform.
Welichem Biotech headquarter office and corporate office address is located in 4475 Wayburne Drive Suite 316 Burnaby, British Columbia V5G 3L1 Canada.
Welichem Biotech was founded in Canada.
In 2024, Welichem Biotech is currently focus on Symbiochem technology platform sector.
Above is snippet of Google Trends for "Symbiochem technology platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Welichem Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
